Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PaSO: Paracetamol with Strong Opioids for Cancer Pain
NCT02706769Terminated
- Sponsor
- University of Edinburgh
- Start
- Nov 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in cancer pain comparing Paracetamol with Placebo (2 arms). Primary endpoint: Proportion of participants with a 30% increase in total Brief Pain Inventory at 14 days. Started Nov 2016; status: terminated.
02
Drugs
acetaminophen
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT02706769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02706769.